Locally Optimised Contouring With AI Technology for Radiotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRoyal North Shore Hospital
About this trial
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring.
LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.
Eligibility criteria
Qualifiers
18 years and older who are planned for primary breast malignancy
ECOG performance 0-2
Ability to understand and willingness to sign a written informed consent document
The target volume must be able to be objectively reviewed by current published national or international clinical guidelines
Disqualifiers
Patients under 18 years of age
Patients unable to understand consent documents
Trial design
Treatments tested in this trial
- AI assisted contouring
Treatment groups
444 Participants
are divided into 2 treatment groupsLocations
3Western Cancer Centre Dubbo2830, DubboNew South Wales, Australia
Central West Cancer Centre2800, OrangeNew South Wales, Australia
Department of Radiation Oncology, Royal North Shore Hospital2065, St LeonardsNew South Wales, Australia
Sponsors and collaborators
Royal North Shore Hospital
Lead sponsor
Source ClinicalTrials.gov